Good and bad times for treating cigarette smoking in drug treatment.

Good and bad times for treating cigarette smoking in drug treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Good and bad times for treating cigarette smoking in drug treatment. Abstract Text:

Kimber P Richter,

Most substance abuse treatment facilities do not routinely treat cigarette smoking even though most of their clients smoke and many will die from tobacco-related illness. This study is a secondary analysis of a national survey of the prevalence and type of tobacco treatment services available in methadone maintenance treatment. It presents qualitative and quantitative information on provider attitudes regarding tobacco treatment in drug treatment. One clinic leader (either a medical director, head nurse, or clinic director) from all 697 U.S. facilities was invited to participate in the study. Most (38%) clinic leaders thought the best time to treat patients for nicotine dependence was whenever the patient wanted treatment. One in four clinic leaders reported they or one of their staff had advised patients to delay quitting smoking cigarettes. Fewer (14%) believed that patients in some way benefited from cigarette smoking; these benefits included managing mood disturbances (calming, reducing anxiety, depression, stress, anger) and substituting for illicit drug abuse. This suggests that some providers might rely on cigarettes in lieu of psychotherapy or prescription medications to address patients' mood disorders such as depression, anger, and anxiety. One tactic for disseminating tobacco treatment in drug treatment might involve identifying the purported benefits of tobacco and training providers in alternative methods for delivering these benefits.

Good and bad times for treating cigarette smoking in drug treatment. Publishing Authors By Initials

KP Richter,

For similar disorders of environmental origin: substance-related disorders research abstracts see: disorders of environmental origin: substance-related disorders research

PUBMED ID PMID:

MEDLINE DATE:

Good and bad times for treating cigarette smoking in drug treatment. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of psychoactive drugs

VOLUME: 38

Page Numbers: 311-5

Journal Abbreviation:

ISSN: 0279-1072

DAY: 3

MONTH: Sep

YEAR: 2006

Good and bad times for treating cigarette smoking in drug treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8113536

Good and bad times for treating cigarette smoking in drug treatment. Keywords Mesh Terms:

KEYWORDS: Substance-Related Disorders

MESH TERMS: therapy

Chemical & Substance for Abstract: Good and bad times for treating cigarette smoking in drug treatment. Information

Substance Name: Methadone

Registry Number: 76-99-3

Grant and Affiliation Information for Good and bad times for treating cigarette smoking in drug treatment.

AFFILIATION: Department of Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, MO, USA. krichter@kumc.edu

Country: United States

AGENCY: United States NIDA

GRANT: K01-DA-00450

ACRONYM: DA

MEDLINETA: J Psychoactive Drugs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Good and bad times for treating cigarette smoking in drug treatment Related Publications

• Analysis of mRNA translation in cultured hippocampal neurons.
• CPEB controls oocyte growth and follicle development in the mouse.
• CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA.
• Cell-based cartilage repair: illusion or solution for osteoarthritis.
• Control of cellular senescence by CPEB.
• Delivery method, anal sphincter tears and fecal incontinence: new information on a persistent problem.
• Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma.
• Embryo transfer in water buffalo (Bubalus bubalis ).
• Gastrooesophageal reflux disease.
• Good and bad times for treating cigarette smoking in drug treatment.
• Helicobacter pylori colonisation and eczema.
• Human let-7a miRNA blocks protein production on actively translating polyribosomes.
• Inhibition of raffinose oligosaccharide breakdown delays germination of pea seeds.
• Mutations within the C-terminus of the gamma subunit of the photosynthetic F1-ATPase activate MgATP hydrolysis and attenuate the stimulatory oxyanion effect.
• Opposing polymerase-deadenylase activities regulate cytoplasmic polyadenylation.
• Optical characterization of hybrid antireflective coatings using spectrophotometric and ellipsometric measurements.
• Optical stimulation of the facial nerve: a new monitoring technique?
• Photovoltaic activity of photosystem I-based self-assembled monolayer.
• Polymethylmethacrylate for managing frontal bone deformities.
• Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
• Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial.
• RINGO/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB.
• Raised speed limits, case fatality and road deaths: a six year follow-up using ARIMA models.
• Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6.
• Structural analysis of the regulatory dithiol-containing domain of the chloroplast ATP synthase gamma subunit.
• The many manifestations of gastroesophageal reflux disease: presentation, evaluation, and treatment.
• Tissue resistivities determine the current flow in the cochlea.
• VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute.
• [5th part: apropos Wenckebach]
• [Introduction to the topic: relative value of injury prevention]